CLA 1000mg
What is CLA?
Conjugated Linoleic Acid (CLA) is a slightly altered form of the
essential fatty acid linoleic acid.
CLA occurs naturally in foods such as cheese, milk, lamb and beef as
well as many processed foods - but only in small amounts. To obtain
therapeutic effects it is therefore best taken as supplement to minimise
calorie and saturated fat intake.
What Does CLA Do?
-
CLA may help to reduce body fat and increase muscle. There are at
least seven human studies (two are double-blind and the others are
controlled) showing significant reduction of abdominal obesity and
body fat mass in overweight and moderately obese people.
-
May enhance athletic performance by reducing body fat and increasing
lean muscle mass.
-
Preliminary animal and test tube research suggests that CLA might
reduce the risk of cancers at several sites, including breast,
prostate, colorectal, lung, skin, and stomach.,,,
Ingredients
Each liquid capsule is a 100% pure and also contains: CLA (80%) 1000mg
Other Ingredients: Gelatin (Vegetable Sourced), Glycerol, Purified
Water, Natural Caramel.
Directions for Use
Studies vary considerably when looking at dosage, but beneficial
effects seem to appear when taking between 1.8 to 4.2mg CLA per day.
With the exception of the cautions indicated below it is generally
considered safe to take between 1-3 Capsules per day with water.
Caution
-
Do NOT exceed the Stated Dose.
-
NOT intended for use by persons under the age of 18.
-
Always consult your GP before taking Nutritional Supplements.
-
Consult you GP if pregnant or lactating
-
Keep out of reach of children.
-
You should not take supplements as a substitute for a varied balanced
diet.
-
Suitable for vegetarians
-
Not suitable for those with or at risk of heart disease,,
-
People with or at risk from diabetes should consult their GP and
carefully monitor blood sugar levels while supplementing CLA as
research is conflicting,,,
-
Free from Gluten, Nuts, Yeast, Salt, Sugar, Artificial Colours,
Flavours and Preservatives.
References
Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces
body fat in healthy exercising humans. J Int Med Res 2001;29:392?6.
Riserus U, Berglund L, Vessby B. Conjugated linoleic acid (CLA) reduced
abdominal adipose tissue in obese middle-aged men with signs of the
metabolic syndrome: a randomised controlled trial. Int J Obes Relat
Metab Disord 2001;25:1129?35.?
Smedman A, Vessby B. Conjugated linoleic acid supplementation in
humans?metabolic effects. Lipids 2001;36:773?81.
Blankson H, Stakkestad JA, Fagertun H, et al. Conjugated linoleic acid
reduces body fat mass in overweight and obese humans. J Nutr
2000;130:2943?8.
Cesano A, Visonneau S, Scimeca JA, et al. Opposite effects of linoleic
acid and conjugated linoleic acid on human prostatic cancer in SCID
mice. Anticancer Res 1998;18:1429-34.
Thompson H, Zhu Z, Banni S, et al. Morphological and biochemical status
of the mammary gland as influenced by conjugated linoleic acid:
implication for a reduction in mammary cancer risk. Cancer Res
1997;57:5067-72.
Ip C. Review of the effects of trans fatty acids, oleic acid, n-3
polyunsaturated fatty acids, and conjugated linoleic acid on mammary
carcinogenesis in animals. Am J Clin Nutr 1997;66(suppl):1523S-29S
[review].
Parodi PW. Cows? milk fat components as potential anticarcinogenic
agents. J Nutr 1997;127:1055-60 [review].
Gaullier JM, Halse J, Hoye K, et al. Conjugated linoleic acid
supplementation for 1 y reduces body fat mass in healthy overweight
humans. Am J Clin Nutr 2004;79:1118?25.
Smedman A, Basu S, Jovinge S, Fredrikson GN, Vessby B. Conjugated
linoleic acid increased C-reactive protein in human subjects. Br J Nutr
2005;94:791?5.
Taylor JS, Williams SR, Rhys R, et al. Conjugated linoleic acid impairs
endothelial function. Arterioscler Thromb Vasc Biol 2006;26:307?12.
Moloney F, Yeow TP, Mullen A, et al. Conjugated linoleic acid
supplementation, insulin sensitivity, and lipoprotein metabolism in
patients with type 2 diabetes mellitus. Am J Clin Nutr 2004;80:887-95.
Riserus U, Vessby B, Arnlov J, Basu S. Effects of cis-9,trans-11
conjugated linoleic acid supplementation on insulin sensitivity, lipid
peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr
2004;80:279?83.
Whigham LD, O'Shea M, Mohede IC, et al. Safety profile of conjugated
linoleic acid in a 12-month trial in obese humans. Food Chem Toxicol
2004 Oct;42(10):1701?9.
Eyjolfson V, Spriet LL, Dyck DJ. Conjugated linoleic acid improves
insulin sensitivity in young, sedentary humans. Med Sci Sports Exerc
2004;36:814?20.
|
